Stage I–II Low-grade Lymphomas: A prospective trial of combination chemotherapy and radiotherapy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/2/suppl_2/137/550173/2-suppl_2-137.pdf
Reference14 articles.
1. Prognostic factors in nodular lymphomas: A multivariate analysis based on the Princess Margaret Hospital experience;Gospodarowicz;Int J Radiat Oncol Biol Phys,1984
2. Analysis of non-Hodgkin's lymphomas with nodular and favorable histologies, stage I and II;Paryani;Cancer,1983
3. Stage I-II follicular lymphoma. Treatment results for 76 patients;McLaughlin;Cancer,1986
4. Treatment of early stages I and II nodular, poorly differentiated lymphocytic lymphoma;Gomez;Am J Clin Oncol,1986
5. Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute;Lawrence;Int J Radiation Oncology Biol Phys,1988
Cited by 37 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapy of nodal Follicular Lymphoma (WHO grade 1/2) in clinical stage I/II using response adapted Involved Site Radiotherapy in combination with Obinutuzumab (Gazyvaro) - GAZAI Trial (GAZyvaro and response adapted Involved-site Radiotherapy): a study protocol for a single-arm, non-randomized, open, national, multi-center phase II trial;Trials;2019-08-30
2. Radiation Therapy in Follicular Lymphoma;Radiation Oncology;2018
3. Dalton’s Lymphoma as a Murine Model for Understanding the Progression and Development of T-Cell Lymphoma and Its Role in Drug Discovery;International Journal of Immunotherapy and Cancer Research;2017-02-01
4. Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study;International Journal of Radiation Oncology*Biology*Physics;2016-03
5. Non-Hodgkin’s Lymphomas, Version 2.2014;Journal of the National Comprehensive Cancer Network;2014-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3